Home/Filings/4/0001537250-13-000002
4//SEC Filing

Harris Robert Paul 4

Accession 0001537250-13-000002

CIK 0001159019other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 7:42 PM ET

Size

12.6 KB

Accession

0001537250-13-000002

Insider Transaction Report

Form 4
Period: 2012-03-22
Harris Robert Paul
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Shares

    2012-03-22$0.56/sh+550,000$308,0007,700,000 total
  • Purchase

    Common Shares

    2012-03-22$0.56/sh+550,000$308,0008,250,000 total(indirect: spousal ownership)
  • Purchase

    Common Shares

    2013-02-27$0.40/sh+625,000$250,0008,875,000 total
  • Purchase

    Warrant A

    2013-02-27$0.50/sh+312,500$156,250312,500 total
    Exercise: $0.50From: 2013-02-27Exp: 2015-02-27Common Share (312,500 underlying)
  • Purchase

    Warrant B

    2013-02-27$0.60/sh+312,500$187,500625,000 total(indirect: Spousal ownership)
    Exercise: $0.60From: 2013-02-27Exp: 2018-02-27Common Share (312,500 underlying)

Issuer

Tribute Pharmaceuticals Canada Inc.

CIK 0001159019

Entity typeother

Related Parties

1
  • filerCIK 0001537250

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 7:42 PM ET
Size
12.6 KB